beta blocker: be less effective in elderly

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be less effective in elderly 1.00
be common in elderly 0.87
is effective 0.80
be effective reducing 0.77
be effective as antianginal medications 0.77
be effective as medications 0.77
be effective in cancer treatment 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.44
Rule weight: 0.66
Evidence weight: 0.87
Similarity weight: 0.75
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.86
¬ Typical(beta blocker, be less effective in elderly)
0.43
Rule weight: 0.66
Evidence weight: 0.74
Similarity weight: 0.87
Evidence: 0.69
Plausible(high blood pressure, be common in elderly)
Evidence: 0.86
¬ Typical(beta blocker, be less effective in elderly)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.85
Similarity weight: 0.87
Evidence: 0.78
Plausible(beta blocker, be less effective in elderly)
Evidence: 0.69
¬ Plausible(high blood pressure, be common in elderly)
0.06
Rule weight: 0.09
Evidence weight: 0.81
Similarity weight: 0.75
Evidence: 0.78
Plausible(beta blocker, be less effective in elderly)
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)

Remarkability exclusitivity betweem a parent and a child

0.35
Rule weight: 0.58
Evidence weight: 0.70
Similarity weight: 0.87
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.58
¬ Remarkable(high blood pressure, be common in elderly)
0.34
Rule weight: 0.58
Evidence weight: 0.78
Similarity weight: 0.75
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)

Remarkability from parent implausibility

0.32
Rule weight: 0.42
Evidence weight: 0.88
Similarity weight: 0.87
Evidence: 0.69
Plausible(high blood pressure, be common in elderly)
Evidence: 0.51
Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.78
¬ Plausible(beta blocker, be less effective in elderly)
0.30
Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.75
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.51
Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.78
¬ Plausible(beta blocker, be less effective in elderly)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.78
Plausible(beta blocker, be less effective in elderly)
Evidence: 0.81
¬ Salient(beta blocker, be less effective in elderly)

Similarity expansion

0.61
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.86
Typical(beta blocker, be less effective in elderly)
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.80
Evidence: 0.86
Typical(beta blocker, be less effective in elderly)
Evidence: 0.80
¬ Typical(beta blocker, is effective)
0.57
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.78
Plausible(beta blocker, be less effective in elderly)
Evidence: 0.57
¬ Plausible(beta blocker, be effective as antianginal medications)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.81
Salient(beta blocker, be less effective in elderly)
Evidence: 0.94
¬ Salient(beta blocker, is effective)
0.56
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.81
Salient(beta blocker, be less effective in elderly)
Evidence: 0.76
¬ Salient(beta blocker, be effective as antianginal medications)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.78
Plausible(beta blocker, be less effective in elderly)
Evidence: 0.82
¬ Plausible(beta blocker, is effective)
0.42
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.80
Evidence: 0.51
Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.79
¬ Remarkable(beta blocker, is effective)
0.39
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.77
Evidence: 0.51
Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.81
Salient(beta blocker, be less effective in elderly)
Evidence: 0.86
¬ Typical(beta blocker, be less effective in elderly)
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.78
Plausible(beta blocker, be less effective in elderly)
Evidence: 0.86
¬ Typical(beta blocker, be less effective in elderly)

Typicality and Rermarkability incompatibility between a parent and a child

0.28
Rule weight: 0.51
Evidence weight: 0.62
Similarity weight: 0.87
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.74
¬ Typical(high blood pressure, be common in elderly)
0.20
Rule weight: 0.51
Evidence weight: 0.52
Similarity weight: 0.75
Evidence: 0.51
¬ Remarkable(beta blocker, be less effective in elderly)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)

Typicality inheritance from parent to child

0.38
Rule weight: 0.48
Evidence weight: 0.89
Similarity weight: 0.87
Evidence: 0.86
Typical(beta blocker, be less effective in elderly)
Evidence: 0.74
¬ Typical(high blood pressure, be common in elderly)
0.32
Rule weight: 0.48
Evidence weight: 0.87
Similarity weight: 0.75
Evidence: 0.86
Typical(beta blocker, be less effective in elderly)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)